Why is the CSL share price sliding lower on Monday?

Investors should be stoked with CSL's share price drop today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a rough start to the week for the S&P/ASX 200 Index (ASX: XJO) and ASX shares. At the time of writing, the ASX 200 has opened 0.14% lower so far this Monday. But let's talk about the CSL Limited (ASX: CSL) share price. 

If you thought the ASX 200's start to the week was disappointing, wait until you see what's going on with CSL shares. The ASX 200 healthcare stock closed last week at a share price of $270.85. But this morning, CSL opened at $269 a share and is currently going for just $266.65 at the time of writing, down a nasty 1.55% for the day so far.

Before any CSL investors get carried away with wondering what's going wrong with their investment today, it's worth pointing out that there's a good reason for CSL's rather steep drop this Monday. This healthcare share has just traded ex-dividend for its upcoming shareholder payment.

woman testing substance in laboratory dish, csl share price

Image source: Getty Images

CSL share price stutters as company trades ex-dividend

Last month, we analysed CSL's latest earnings report, covering the full 2023 financial year. It was a well-received earnings report at the time, with the healthcare giant revealing that it had managed to grow revenues by a healthy 31% in constant currency terms to US$13.31 billion.

Net profits after tax before amortisation rose by 20% in constant currency to US$2.86 billion, while reported net profits lifted by 10% to US$2.61 billion.

That enabled CSL to boost its final dividend for 2023 by 9.3% to US$1.29 per share, partially franked at 10%. That's the largest dividend CSL has ever paid out. This payment takes the company's full-year dividends to US$2.36 per share, up 6% from last year.

However, as we warned last week, CSL's ex-dividend date for this supersized shareholder payment is today. This means that anyone buying CSL shares from today onwards is not eligible to receive this latest dividend.

That's why we are seeing such a dramatic fall in the CSL share price this Monday relative to the ASX 200. It usually happens when an ASX share trades ex-dividend, and reflects this inherent loss of value for new investors going forward.

So existing CSL investors have nothing to complain about with their company seeing a share price drop today. It's the best reason to see a company have a red day on the markets.

CSL shareholders can now look forward to receiving their latest dividend next month on 4 October.

Right now, CSL shares have a dividend yield of 1.15%. The CSL share price remains down by 5.5% in 2023 to date, as well as by 10.1% over the past 12 months, as you can see below:

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientists in white coats look disappointed.
Healthcare Shares

$5,000 invested in CSL shares 12 months ago is now worth…

Are the biotech company's shares worth holding onto?

Read more »

Happy healthcare workers in a lab.
Healthcare Shares

Clarity Pharmaceuticals shares are up 12% today. Here's what's driving the move

Today's announcement moves Clarity a step closer towards commercialisation.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

Which ASX biotech's shares are rocketing higher on big US news?

This company has more than doubled in value over the past three months.

Read more »

A man with a wry smile on his face is shown close up behind ascending piles of coins as he places another coin on top of the tallest stack representing rising dividends
Healthcare Shares

Here's the dividend forecast out to 2030 for CSL shares

Can healthy dividends continue from CSL?

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Forget CSL shares, this ASX healthcare stock could double in value

Brokers see significantly more upside ahead for Pro Medicus.

Read more »

Lab worker puts hands in the air and dances around.
Healthcare Shares

CSL shares look primed to take off — Here's why

Business remains robust and brokers see ASX stock soaring up to 100%.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

ASX 300 healthcare stock outperforming today on 'strategic' leadership news

The ASX healthcare stock announced the outcome of its CEO recruitment drive this morning.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »